Matt focuses his corporate transactional practice on helping his clients solve the increasingly complex and sophisticated challenges of acquisitions, financings, and governance matters.
Leveraging his broad skill set and unique background as an international negotiator, Matt serves as a strategic counselor to his clients, working with them to structure, negotiate, and execute various transactional arrangements, including mergers and acquisitions, growth equity investments, joint ventures and other financings. Matt also serves as outside general counsel to several early stage clients, advising them on all aspects of their legal needs. Matt’s clients span a broad range of corporate organizations, including well-known private equity sponsors, large multi-national corporations, and both early-stage and late-stage grown companies, across a variety of industries including technology, pharmaceuticals, life sciences, telecommunications, financial services, consumer products, energy, and manufacturing, among others.
Prior to joining Mintz, Matt worked at the New York office of Torys LLP and the Washington, DC office of Weil Gotshal. Prior to law firm service, Matt ran the sales department of the then-largest college marketing program where he sold $1 million+ marketing programs to Fortune 500 companies.
In addition to his corporate practice, Matt is a recognized international negotiator and legal advisor. In 2010 the United Nations and African Union appointed Matt the Principal Legal Advisor to the Darfur Delegation in the Darfur Peace Negotiations. Embedded in Doha, Qatar as an official member of the Darfur delegation, Matt lead a team of over two dozen international legal and policy advisors on all aspects of the peace negotiations including issues related to power and wealth sharing, the negotiation of a $2 billion development fund, the overhaul of the petroleum and natural resources sectors, and the formation of a regional government for Darfur. From 2006 to 2011, Matthew was affiliated with the Public International Law & Policy Group (PILPG) in Washington, DC where he worked on over a dozen post-conflict legal and policy initiatives including leading the first-ever surrender to the International Criminal Court, amending the Iraqi Constitution, designing war crimes witness protection programs in Uganda, and advising on the establishment of the Republic of South Sudan.
During law school, Matthew was an editor of the American University International Law Review and was the president and co-founder of the International Trade Law Society at American University.
- American University (JD, cum laude)
- American University (MA, International Affairs)
- Hobart College (BA, cum laude, highest honors)
- A global financial services firm in the acquisition of the assets of a financial services provider.
- A leading investment advisory/broker dealer firm in the strategic acquisition of a rival’s advisors and other assets.
- A middle-market private equity fund in the acquisition of a consumer products portfolio company.
- A national wholesale grocery company on the acquisition of a grocery distribution company’s assets.
- A wastewater treatment company on an innovative project financing structure.
- A solar distributor on the sale of its EPC business and the development industry-leading debt financing arrangements.
- A solar developer in the debt and equity financings of various solar projects.
- A venture-backed technology company on the sale of its assets to a strategic investor.
- An early-stage technology company on the merger of its assets and management team with a foreign rival.
- Mintz represented Kimberly-Clark Corporation in selling its transdermal, micro-needle drug delivery division (Sofusa) to Sorrento Therapeutics for a total of $310M ($10M upfront + $300M in milestones and earn-outs). Mintz will represent the newly-formed Sorrento division going forward.
- Mintz represented KeraNetics in its merger with Microchips Biotech, forming a new company known as Keratin Biosciences. The company, which will maintain locations in Winston-Salem, North Carolina, and Lexington, Massachusetts, will focus on effectively delivering keratin-based regenerative medicine developed by KeraNetics via Microchips’ proprietary microchip implant which stores and releases drug doses over extended periods.
- Mintz represented the leadership of newly-formed Viela Bio in its spin-out from AstraZeneca’s MedImmune division. The spin-out included investment by AstraZeneca, 6 Dimensions Capital, Boyu Capital, Hillhouse Capitals, Temasek, and Sirona Capital. Viela Bio will build itself around three clinical and preclinical compounds targeting inflammatory and autoimmune diseases, including one which is in Phase II development.
Recognition & Awards
- Washington D.C. Super Lawyers: Rising Star (2015 - 2018)
- Former Competitive Sailor: North American, National, and Provincial Champion (1993-2000)
- Hobart College Alumni Association – Executive Committee Member at Large
- Registered Expert, ABA/UNDP International Law Resource Centre
- Member, International Network to Promote the Rule of Law (INPROL)
- Member, CANADEM Experts Roster
- Former Co-Chair, Hobart and William Smith Colleges Alumni Association, Washington, DC
- Former Vice-Chairman, American Bar Association- International Trade Committee